<DOC>
	<DOCNO>NCT02057302</DOCNO>
	<brief_summary>Dyslipidemia contribute greatly formation progression atherosclerosis ( AS ) , play dominant role lead CHD . Xuezhikang partially purify extract ferment red yeast rice ( Monascus purpureus ) . It compose 13 kind natural statin , unsaturated fatty acid , ergosterol , amino acid , flavonoid , alkaloid , trace element , forth . Xuezhikang recommend guideline China adult dyslipidemia prevention . This study aim evaluate benefit side effect Xuezhikang , potential alternative drug statin , patient dyslipidemia , thus provide evidence clinical application .</brief_summary>
	<brief_title>A Study Postmarketing Xuezhikang Capsule Treating Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>1 . Age : 18 year 75 year 2 . Patients Dyslipidemia diagnose accord standard western medicine diagnosis criterion 3 . TCM syndrome patient dyslipidemia diagnose accord standard TCM syndrome diagnosis criterion 4 . Patients take lipid lower drug stop take least two week take part study 5 . Patients agree participate study sign informed consent form 1 . Pregnant ( positive pregnancy test within 7 day start treatment ) , lactate woman . 2 . Patients Homozygous Familial Hypercholesterolemia 3 . Patients know allergy Chinese medicine drug 4 . Patients acute myocardial infarction , cerebrovascular accident , severe trauma , major surgery cancer half year . 5 . AST ALT level increase least twice upper limit normal patient 6 . Patients take part clinical trial influence result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Xuezhikang Dyslipidemia chinese medicine RCT</keyword>
</DOC>